Author

Prajakta Bhanap

Thermo Fisher Scientific (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1

Frequent Co-Authors

Yongchang Ji· 2 shared Aidan Retherford· 1 shared Alexandre GirardiD· 1 shared Alice MelocchiiD· 1 shared Andrew ScheffleriD· 1 shared Angela LaresiD· 1 shared Brigitte Schmittlein· 1 shared Christopher Cheng· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Yongchang Ji

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Performance of a Modular Robotic Cluster Matches Skilled Human Operators for Complex Cell Therapy Manufacturing Tasks

Sudeshna Sadhu, Brigitte Schmittlein, Angela Lares, Christopher Cheng, Xiaojie Chen, Varun Bhatia, Winston Zha, Sebastien Wah, Sunaina Nayak, Marco Uboldi, Yifan Yu, Jiawei Wang, Wei Zhang, Prajakta Bhanap, Yongchang Ji, , Jonathan H. Esensten

A modular robotic system performs key unit operations in cell therapy manufacturing with accuracy comparable to human operators while ensuring throughput and flexibility.

International Journal of Pharmaceutics X · Aug 4, 2026Peer-reviewedBioengineering

Accelerating CAR T cell manufacturing with an automated next-day process

Moloud Ahmadi, Nicholas Putnam, Max Dotson, Danny Hayoun, Jasmine Padilla, Nujhat Fatima, Prajakta Bhanap, Gertrude Nonterah, Xavier de Mollerat du Jeu, Yongchang Ji

This study introduces an automated 24-hour CAR T cell manufacturing process that increases naive/stem-cell like T cells and cytotoxic activity, potentially improving therapy efficacy and patient access.

Current Research in Translational Medicine · Dec 7, 2024Peer-reviewedBioengineering